As China Struggles to Control Outbreak, Experts Question Zero-COVID Strategy 06/04/2022 Aishwarya Tendolkar China’s COVID-19 situation is getting worse, and strategies to control the spread of the Omicron variant are getting stricter as the country registered 20,472 daily cases on Wednesday – the highest-ever infection rate. The epicentre of the outbreak is Shanghai, which recorded 17,007 cases on Wednesday and municipal authorities are conducting mass testing in the […] Continue reading -> COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Pandemic Has Highlighted the Importance of ‘One Health’ Collaborations 01/04/2022 Maayan Hoffman The COVID-19 pandemic has pushed the scientific community to start to implement a ‘One Health’ approach – encompassing people, animals, plants and the environment – to ensure the early identification of infectious diseases and make the world a healthier place. The issues that “One Health” may tackle are diverse. They can range from curbing deforestation […] Continue reading -> Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s 28/03/2022 Maayan Hoffman A second booster of the Pfizer COVID-19 vaccine reduced mortality rates among elderly people in Israel by 78%, according to a new study by the country’s Clalilt Health Services, Sapir College and Ben-Gurion University. This is the largest study of its kind to date, and involved more than 560,000 people aged 60. “The main conclusion […] Continue reading -> UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Environment Programme Joins WHO Alliance to Advance One Health Approach 18/03/2022 Editorial team UN Environment has joined a three-way alliance with the Food and Agriculture Organization, the World Animal Health Organization (OIE), and WHO to advance “One-Health” solutions to both ecosystem degradation and pandemic threats, leaders of the four agencies said on Friday. The statement followed a meeting this week of the Tripartite FAO, WHO and OIE partnership […] Continue reading -> Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fourth COVID Vaccine Jab Provides Little Extra Protection to Healthy Individuals – NEJM 16/03/2022 Maayan Hoffman A month after a fourth dose of the Pfizer or Moderna vaccines was administered to hundreds of people in an Israeli clinical trial, authors of the new study on the extra booster say it provides “little protection, if any, from infection by COVID-19 among vaccinated young and healthy individuals in comparison to those vaccinated with […] Continue reading -> Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Waives its COVID Patents Permanently – But Won’t Share Tech with South African mRNA Hub 08/03/2022 Kerry Cullinan Moderna has committed to permanently waiving its COVID-19 patents in 92 low- and middle-income countries, and is pursuing vaccines for 15 diseases identified as the world’s biggest public health risk, including ebola, tuberculosis and malaria. The company has also offered outside researchers access to its mRNA technology to pursue research on emerging and neglected infectious […] Continue reading -> Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mind the Animals: Call for Regulation of Wildlife to Prevent COVID ‘Reservoirs’ 08/03/2022 Aishwarya Tendolkar Countries need to prevent more SARS-CoV2 infections in wildlife, as this could result in the establishment of animal reservoirs, according to a joint statement by the World Health Organisation, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (OIE). So far domestic animals, free-ranging, captive or farmed wild animals such as big […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 28/02/2022 Kerry Cullinan Three pre-print papers published over the past few days have strengthened the case for the theory that SARS-COV2 first spread among people via infected animals sold and slaughtered at the Huanan wildlife market in Wuhan – rather than from the Wuhan Institute of Virology, the laboratory studying coronaviruses in bats. The two theories have been […] Continue reading -> Posts navigation Older postsNewer posts